Xencor Names Bart Cornelissen as SVP and Chief Financial Officer
Xencor Names Bart Cornelissen as SVP and Chief Financial Officer
Xencor Inc., a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, has appointed Bart Cornelissen [alumnus RSM MScBA] as senior vice president and chief financial officer.
Read the article: https://www.contractpharma.com/contents/view_breaking-news/2024-04-09/xencor-names-bart-cornelissen-as-svp-and-chief-financial-officer/
Participants
Bart Cornelissen
Role: Alumni
Reference type: Featured
Media Outlets
Contract Pharma (Online)
RSM uses cookies to measure website statistics, enable social media sharing and for marketing purposes.
By clicking accept cookies or by continuing to use this website, you are giving consent for us to set cookies when visiting this website.
See our cookie policy for more information about cookies and how to adjust your cookie settings.